We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Ombudsman Clears EMA Over Decision to Redact Clinical Trial Reports
EU Ombudsman Clears EMA Over Decision to Redact Clinical Trial Reports
The European Medicines Agency’s decision to redact certain personal and commercial information from clinical study reports before releasing them to a private citizen did not violate EU transparency policy, the European ombudsman says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor